Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Sale of 797 PTHS shares, $16.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 797 | $16.9K |
| Jul 7, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 712 | $18.5K |
| Apr 6, 2026 | Pelthos Therapeutics Inc. (PTHS) | Sale | 420 | $8.6K |
| Mar 3, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 196,403 | n/a |
| Feb 23, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax Withholding | 100,171 | $1.44M |
| Jan 5, 2026 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 165,384 | n/a |
| Jul 8, 2025 | Pelthos Therapeutics Inc. (PTHS) | Grant/Award | 25,478 | n/a |
| Mar 5, 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 290,728 | n/a |
| Mar 7, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale | 126,981 | $711.1K |
| Feb 22, 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/Award | 661,538 | n/a |